Ignalis-M 50/500 Tablet ER
By Ignalis-M
Rx
10 Tablet ER in a Strip

Composition
Sitagliptin(50mg) + Metformin(500mg)

Manufacturer - Intas Pharmaceuticals Ltd
Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Expires on or after
June, 2026
About Ignalis-M 50/500 Tablet ER
Ignalis-M 50/500 Tablet ER is a combination medication used to manage high blood sugar levels in individuals with type 2 diabetes mellitus. By controlling blood sugar levels effectively, this medication helps reduce the risk of complications such as kidney damage, blindness, heart attacks, and strokes. It can be prescribed alone or in combination with other diabetes medications, working best when complemented with a healthy diet and regular exercise routine. Your prescribed dosage will depend on your condition, blood sugar levels, and other medications you may be taking. Taking Ignalis-M 50/500 Tablet ER with meals can help minimize the likelihood of experiencing stomach upset.
Consistency is key when taking Ignalis-M 50/500 Tablet ER, so it is important to take it at the same time each day to maximize its benefits. It is crucial not to discontinue the medication unless advised by your doctor, as maintaining proper lifestyle habits like diet and exercise is essential in managing diabetes. Common side effects of Ignalis-M 50/500 Tablet ER may include diarrhea, nausea, vomiting, headache, upset stomach, and sore throat. Additionally, low blood sugar levels (hypoglycemia) may occur, especially if Ignalis-M 50/500 Tablet ER is taken alongside other diabetes medications like insulin or sulfonylurea. It is important to recognize the symptoms of hypoglycemia and know how to address it.
Before starting Ignalis-M 50/500 Tablet ER, inform your doctor about any history of kidney, liver, or heart disease, pancreas issues, or excessive alcohol consumption. Pregnant or breastfeeding individuals should seek medical advice before using this medication. It is also essential to disclose all other medications you are taking to ensure safety. Regular monitoring of kidney function and blood sugar levels will be conducted by your doctor throughout the treatment course.
Ignalis-M 50/500 Tablet ER contains a combination of Sitagliptin (DPP4 inhibitors) and Metformin (Biguanides), both belonging to the class of anti-diabetic drugs. Sitagliptin aids in lowering blood sugar levels by increasing certain natural substances, while Metformin reduces glucose production in the liver and enhances the body's sensitivity to insulin. These mechanisms help prevent blood sugar spikes post-meals. It is recommended to take Ignalis-M 50/500 Tablet ER with food to avoid stomach issues and adhere to the prescribed dosing schedule for optimal results.
Please consult your doctor if you experience any side effects from Ignalis-M 50/500 Tablet ER, such as hypoglycemia, taste changes, stomach discomfort, headache, or upper respiratory symptoms. Do not stop taking the medication abruptly without medical guidance, as proper management is vital in preventing complications associated with uncontrolled diabetes. Ignalis-M 50/500 Tablet ER is not suitable for individuals with type 1 diabetes mellitus, severe kidney or liver disease, or certain heart conditions. Lifestyle modifications, including a healthy diet, regular exercise, and avoiding alcohol consumption, are important aspects of diabetes management when using this medication.
Benefits
Ignalis-M 50/500 Tablet ER is a medication used to treat Type 2 diabetes mellitus. It contains a combination of two medicines that work together to lower blood glucose levels. Managing diabetes is crucial in preventing serious complications such as kidney damage, eye damage, nerve issues, and limb loss. By controlling blood sugar levels with this medication, you can also reduce the risk of heart disease and stroke.
The medication works by blocking the action of an enzyme called DPP-4, which plays a key role in regulating insulin production and blood sugar levels. This helps the body produce more insulin only when necessary and prevents the liver from producing excess sugar. By maintaining proper blood sugar levels, Ignalis-M 50/500 Tablet ER reduces the risk of complications like retinopathy, nephropathy, neuropathy, diabetic foot ulcers, and delayed wound healing.
Taking Ignalis-M 50/500 Tablet ER regularly, along with a balanced diet and exercise, can help you lead a normal and healthy life. It is important to continue using this medication as prescribed to protect your future health. By incorporating this medication into your diabetes management routine, you can effectively control your blood sugar levels and minimize the risk of serious diabetes-related complications.
How to use the Ignalis-M 50/500 Tablet ER
To use Ignalis-M 50/500 Tablet ER, follow the instructions given by your doctor carefully. This medication should be taken in the dose and duration recommended by your doctor. Swallow the tablet whole with a glass of water, preferably with food. Do not crush, chew, or break the tablet. Your doctor will determine the correct dosage and treatment duration based on factors such as your age, body weight, and the condition being treated. It is important not to stop taking Ignalis-M 50/500 Tablet ER unless your doctor specifically advises you to do so. If you have any questions or concerns about how to use this medication, consult your doctor for further guidance.
Uses of Ignalis-M 50/500 Tablet ER
Ignalis-M 50/500 Tablet ER is commonly used for the treatment of Type 2 diabetes mellitus. It is specifically designed to help manage this condition. Type 2 diabetes mellitus refers to a chronic condition where the body experiences difficulty in utilizing insulin effectively, leading to high blood sugar levels. Patients with type 2 diabetes mellitus can benefit from using Ignalis-M 50/500 Tablet ER to help regulate their blood sugar levels and improve overall control of the condition. This medication plays a crucial role in the management of type 2 diabetes mellitus, and when used as per the healthcare provider's instructions, it can support patients in effectively addressing the symptoms and complications associated with this condition.
What conditions Ignalis-M 50/500 Tablet ER treats?
Ignalis-M 50/500 Tablet ER is used in the management of type 2 diabetes. Type 2 diabetes is a condition where the body struggles to produce enough insulin or utilize it effectively, leading to high blood sugar levels. Symptoms may include increased thirst, frequent urination, slow wound healing, increased hunger, fatigue, and blurred vision. Complications of type 2 diabetes can involve nerve problems, kidney problems, eye damage or blindness, limb amputation, sexual dysfunction, and an elevated risk of heart attack or stroke. Weight fluctuations may also occur in some cases.
Should you consult a doctor?
Seek medical attention if you experience severe, uncontrollable diabetes, nausea, vomiting, diarrhea, rapid weight loss, lactic acidosis, ketoacidosis, dehydration, systemic infection, shock, blood circulation issues, breathing difficulties, are an alcoholic, or scheduled for upcoming X-rays. Inform your doctor before taking Ignalis-M 50/500 Tablet ER 50/500 Tablet ER if you have a history of pancreatitis, alcohol dependence, high blood lipids, type I diabetes, major surgery upcoming, fasting, malnutrition, extreme exercise, or vitamin B12 deficiency.
Side effects of Ignalis-M 50/500 Tablet ER
Ignalis-M 50/500 Tablet ER may cause some side effects while your body adjusts to the medicine. These side effects are generally mild and temporary. Side effects may include decreased appetite, vomiting, upper respiratory tract infections, hypoglycemia (low blood glucose level), abdominal bloating, nausea, and diarrhea. It's essential to keep in mind that not all individuals will experience these side effects, and some may not experience any at all.
Other possible side effects of Ignalis-M 50/500 Tablet ER may include drowsiness, dizziness, dry mouth, headache, skin itching, and upper respiratory tract infections like nasopharyngitis. If you notice any of the following severe side effects, stop taking the medication and seek immediate medical attention: serious allergic reactions such as hives, swelling of the face, lips, tongue, or throat leading to difficulty breathing or swallowing; severe blistering of the skin, indicating an allergic skin reaction known as bullous pemphigoid; signs of pancreatitis like severe and persistent stomach pain with or without nausea and vomiting; signs of lactic acidosis such as cold extremities, dizziness, irregular heartbeat, muscle pain, breathing difficulties, sleepiness, stomach pains, nausea, or vomiting.
Further side effects that warrant medical attention include hypoglycemia, nausea, vomiting, flatulence, diarrhea, constipation, stomach pain, loss of appetite, swelling in the hands and legs (edema), stuffy nose, sore throat, and joint or limb pain. It's important to consult your healthcare provider if you experience any persistent or concerning side effects while taking Ignalis-M 50/500 Tablet ER.
Safety advice

liver
Ignalis-M 50/500 Tablet ER may not be suitable for individuals with liver disease and is advised to be avoided. It is recommended to seek guidance from your doctor before using this medication to ensure safety and effectiveness.

kidney
Ignalis-M 50/500 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during use. Consult your doctor.

alcohol
It is not safe to drink alcohol while taking Ignalis-M 50/500 Tablet ER.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Ignalis-M 50/500 Tablet ER as it may impact your ability to drive safely.

pregnancy
Ignalis-M 50/500 Tablet ER is not recommended during pregnancy as it may be harmful to the developing baby based on animal studies. Your doctor will assess the potential risks versus benefits before prescribing it to you. Please consult your doctor.

breastfeeding
Caution advised while breastfeeding as Ignalis-M 50/500 Tablet ER may be unsafe. Limited data shows drug may pass into breastmilk and harm baby.
Age above 75(Geriatrics)
Ignalis-M 50/500 Tablet ER TABLET should be used with caution in elderly patients (aged above 65 years). Therefore, consult your doctor before taking it.
Age below 6 months(Pediatrics)
Ignalis-M 50/500 Tablet ER TABLET is not recommended for use in children and adolescents (aged below 18 years). However, consult your doctor before taking it.
Consumption warning before consuming Ignalis-M 50/500 Tablet ER
Before taking Ignalis-M 50/500 Tablet ER, inform your doctor if you are allergic to sitagliptin, any other medications, foods, or any components present in the tablet. Prolonged use of Ignalis-M 50/500 Tablet ER may lead to acute pancreatitis and severe kidney problems. There is an increased risk of low blood sugar levels when Ignalis-M 50/500 Tablet ER is combined with other anti-diabetic medications or insulin therapy, requiring potential dosage adjustments. Some patients may experience severe allergic reactions such as anaphylaxis, angioedema, or Stevens-Johnson syndrome while using Ignalis-M 50/500 Tablet ER. It is important to note that the safety and effectiveness of Ignalis-M 50/500 Tablet ER in individuals under 18 years old have not been established, thus this medication is not recommended for pediatric use. If you are taking digoxin for heart conditions along with Ignalis-M 50/500 Tablet ER, close monitoring for potential drug interactions is necessary.
Disease interactions
When considering the use of Ignalis-M 50/500 Tablet ER, it is important to take into account certain factors related to specific health conditions. Patients with a history of pancreatitis or pancreatic disease should use Alsita-50 Tab 10'S with caution. Additionally, individuals with renal dysfunction should also be cautious when using this medication. It is advisable to consult with a healthcare professional before starting Ignalis-M 50/500 Tablet ER if you have a history of pancreatitis, pancreatic disease, or renal issues to ensure safe and effective treatment.
What if you forgot to take Ignalis-M 50/500 Tablet ER?
If you forget to take your Ignalis-M 50/500 Tablet ER, try to take it as soon as you remember. But if it's near the time for your next dose, just skip the missed one and stick to your usual dosing schedule. Avoid taking a double dose to make up for the missed one. Remember to keep track of when you should take your next dose to maintain the effectiveness of your medication.
What happens if you take overdose of Ignalis-M 50/500 Tablet ER?
If you suspect that you or someone else has taken too much Ignalis-M 50/500 Tablet ER, it is crucial to seek medical help promptly. An overdose of this medication can lead to various symptoms, such as feeling cold or uncomfortable, severe nausea or vomiting, stomach pain, unexplained weight loss, muscular cramps, and fast breathing. Remember to consult your doctor or go to the nearest hospital if you experience any of these signs of an overdose.
Related lab tests
When taking Ignalis-M 50/500 Tablet ER, it's important to monitor your blood glucose levels regularly through various lab tests. Related lab tests for monitoring include:
1. Blood Glucose - Fasting: This test measures the glucose levels in your blood after fasting for a certain period, usually overnight. It gives an overview of your baseline glucose levels.
2. Blood Glucose - Postprandial: This test measures the glucose levels in your blood after a meal, usually taken 2 hours after eating. It helps assess how your body processes glucose after consuming food.
3. Glycosylated Hemoglobin (HbA1C): Also known as Glycated Hemoglobin, this test gives an average of your blood sugar levels over the past 2-3 months. It is a key indicator of how well your blood sugar has been controlled over time.
Monitoring these lab tests regularly while taking Ignalis-M 50/500 Tablet ER can help you and your healthcare provider in managing your diabetes effectively.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹119.25
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024